Projects per year
Abstract
Clinical response to methotrexate (MTX) treatment for children with juvenile idiopathic arthritis (JIA) displays considerable heterogeneity. Currently, there are no reliable predictors to identify non-responders: earlier identification could lead to a targeted treatment. We genotyped 759 JIA cases from the UK, the Netherlands and Czech Republic. Clinical variables were measured at baseline and 6 months after start of the treatment. In Phase I analysis, samples were analysed for the association with MTX response using ordinal regression of ACR-pedi categories and linear regression of change in clinical variables, and identified 31 genetic regions (P
Original language | English |
---|---|
Pages (from-to) | 356-364 |
Number of pages | 8 |
Journal | The pharmacogenomics journal |
Volume | 14 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2014 |
Fingerprint
Dive into the research topics of 'Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases.'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Arthritis Research UK Centre of Excellence in Epidemiology.
Symmons, D., Bruce, I., Dixon, W., Felson, D., Hyrich, K., Lunt, M., Mcbeth, J., O'Neill, T. & Verstappen, S.
1/08/13 → 31/07/18
Project: Research